Based on the successful results of collaboration with the World Health Organization (WHO) in carrying out jointly planned activities, Almazov Centre was reassigned the official status of a WHO Collaborating Centre for CVDs, eHealth and value-based medicine until 2026.
Almazov Centre has been collaborating with WHO since 2018 in the areas of NCDs epidemiology, CVD risk factors, emergency care, primary and secondary prevention and rehabilitation, decision support systems for better medical care and prevention, value-based care and personalized medicine and their use in the field of NCDs and CVDs.
As part of collaboration with WHO, Almazov Centre held 2 strategic sessions and 1 flagship seminar involving WHO experts. Experts from Almazov Centre visited the Central Asian countries (Turkmenistan, Kyrgyzstan). Based on the results of 3 missions, strategic documents were published on the establishment and development of medical care systems for heart attack and stroke. In 2022, the experts of Almazov Centre were involved in the updating of clinical protocols on non-communicable diseases for the project “Procurement of medicines and health products for the control of non-communicable diseases (NCD) in Turkmenistan through the United Nations Development Programme.”
Today, there are more than 700 WHO collaborating centres in 80 countries working with WHO on areas such as nursing, occupational health, communicable diseases, nutrition, mental health, chronic diseases and health technologies. Almazov Centre is one of the 23 WHO collaborating centres in Russia.